Literature DB >> 21381185

Paper 6: EUROCAT member registries: organization and activities.

Ruth Greenlees1, Amanda Neville, Marie-Claude Addor, Emmanuelle Amar, Larraitz Arriola, Marian Bakker, Ingeborg Barisic, Patricia A Boyd, Elisa Calzolari, Berenice Doray, Elizabeth Draper, Stein Emil Vollset, Ester Garne, Miriam Gatt, Martin Haeusler, Karin Kallen, Babak Khoshnood, Anna Latos-Bielenska, Maria-Luisa Martinez-Frias, Anna Materna-Kiryluk, Carlos Matias Dias, Bob McDonnell, Carmel Mullaney, Vera Nelen, Mary O'Mahony, Anna Pierini, Annette Queisser-Luft, Hanitra Randrianaivo-Ranjatoélina, Judith Rankin, Anke Rissmann, Annukka Ritvanen, Joaquin Salvador, Antonin Sipek, David Tucker, Christine Verellen-Dumoulin, Diana Wellesley, Wladimir Wertelecki.   

Abstract

BACKGROUND: EUROCAT is a network of population-based congenital anomaly registries providing standardized epidemiologic information on congenital anomalies in Europe. There are three types of EUROCAT membership: full, associate, or affiliate. Full member registries send individual records of all congenital anomalies covered by their region. Associate members transmit aggregate case counts for each EUROCAT anomaly subgroup by year and by type of birth. This article describes the organization and activities of each of the current 29 full member and 6 associate member registries of EUROCAT.
METHODS: Each registry description provides information on the history and funding of the registry, population coverage including any changes in coverage over time, sources for ascertaining cases of congenital anomalies, and upper age limit for registering cases of congenital anomalies. It also details the legal requirements relating to termination of pregnancy for fetal anomalies, the definition of stillbirths and fetal deaths, and the prenatal screening policy within the registry. Information on availability of exposure information and denominators is provided. The registry description describes how each registry conforms to the laws and guidelines regarding ethics, consent, and confidentiality issues within their own jurisdiction. Finally, information on electronic and web-based data capture, recent registry activities, and publications relating to congenital anomalies, along with the contact details of the registry leader, are provided.
CONCLUSIONS: The registry description gives a detailed account of the organizational and operational aspects of each registry and is an invaluable resource that aids interpretation and evaluation of registry prevalence data.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21381185     DOI: 10.1002/bdra.20775

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  39 in total

1.  Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening.

Authors:  Maria Loane; Joan K Morris; Marie-Claude Addor; Larraitz Arriola; Judith Budd; Berenice Doray; Ester Garne; Miriam Gatt; Martin Haeusler; Babak Khoshnood; Kari Klungsøyr Melve; Anna Latos-Bielenska; Bob McDonnell; Carmel Mullaney; Mary O'Mahony; Annette Queisser-Wahrendorf; Judith Rankin; Anke Rissmann; Catherine Rounding; Joaquin Salvador; David Tucker; Diana Wellesley; Lyubov Yevtushok; Helen Dolk
Journal:  Eur J Hum Genet       Date:  2012-06-20       Impact factor: 4.246

2.  Response to: Case-control studies require appropriate population controls: an example of error in the SSRI birth defect literature.

Authors:  Helen Dolk; Anthony Wemakor
Journal:  Eur J Epidemiol       Date:  2015-11-30       Impact factor: 8.082

3.  Authors' reply to Smith and colleagues.

Authors:  James L Mills; Aggeliki Dimopoulos
Journal:  BMJ       Date:  2016-02-16

4.  Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.

Authors:  Anthony Wemakor; Karen Casson; Ester Garne; Marian Bakker; Marie-Claude Addor; Larraitz Arriola; Miriam Gatt; Babak Khoshnood; Kari Klungsoyr; Vera Nelen; Mary O'Mahoney; Anna Pierini; Anke Rissmann; David Tucker; Breidge Boyle; Lolkje de Jong-van den Berg; Helen Dolk
Journal:  Eur J Epidemiol       Date:  2015-07-07       Impact factor: 8.082

5.  Identifying signals of potentially harmful medications in pregnancy: use of the double false discovery rate method to adjust for multiple testing.

Authors:  Alana Cavadino; David Prieto-Merino; Joan K Morris
Journal:  Br J Clin Pharmacol       Date:  2018-11-26       Impact factor: 4.335

6.  The risk for four specific congenital heart defects associated with assisted reproductive techniques: a population-based evaluation.

Authors:  Karim Tararbit; Nathalie Lelong; Anne-Claire Thieulin; Lucile Houyel; Damien Bonnet; François Goffinet; Babak Khoshnood
Journal:  Hum Reprod       Date:  2012-11-22       Impact factor: 6.918

7.  Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection.

Authors:  Linda de Jonge; Priscilla A Zetstra-van der Woude; H Jens Bos; Lolkje T W de Jong-van den Berg; Marian K Bakker
Journal:  Drug Saf       Date:  2013-11       Impact factor: 5.606

8.  Underreporting of congenital rubella in Italy, 2010-2014.

Authors:  Cristina Giambi; Antonino Bella; Antonietta Filia; Martina Del Manso; Gloria Nacca; Silvia Declich; Maria Cristina Rota
Journal:  Eur J Pediatr       Date:  2017-05-28       Impact factor: 3.183

9.  Periconceptional folic acid associated with an increased risk of oral clefts relative to non-folate related malformations in the Northern Netherlands: a population based case-control study.

Authors:  Anna M Rozendaal; Anthonie J van Essen; Gerard J te Meerman; Marian K Bakker; Jan J van der Biezen; Sieneke M Goorhuis-Brouwer; Christl Vermeij-Keers; Hermien E K de Walle
Journal:  Eur J Epidemiol       Date:  2013-10-04       Impact factor: 8.082

10.  Long-term hospital admissions and surgical treatment of children with congenital abdominal wall defects: a population-based study.

Authors:  Arimatias Raitio; Johanna Syvänen; Asta Tauriainen; Anna Hyvärinen; Ulla Sankilampi; Mika Gissler; Ilkka Helenius
Journal:  Eur J Pediatr       Date:  2021-03-05       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.